| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967833 | Vaccine | 2012 | 9 Pages |
Abstract
⺠A glycan placed on the perimeter of the gp120 CD4bs restricts antibody access. ⺠Adjuvant Quil A modulates antibody fine specificity. ⺠Adjuvant Quil A promotes antibody responses to the CD4-binding site. ⺠The elicited CD4bs antibody titers are too low to achieve significant neutralizing activity.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Fatima K. Ahmed, Brenda E. Clark, Dennis R. Burton, Ralph Pantophlet,